Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
- PMID: 21461938
- PMCID: PMC3072506
- DOI: 10.1007/s10194-011-0334-4
Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
Comment on
-
Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.J Headache Pain. 2011 Apr;12(2):135-6. doi: 10.1007/s10194-011-0333-5. Epub 2011 Mar 27. J Headache Pain. 2011. PMID: 21442332 Free PMC article. No abstract available.
References
-
- Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26:742–746. doi: 10.1111/j.1468-2982.2006.01172.x. - DOI - PubMed
-
- Dodick DW, Turkel CC, Degryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, on behalf of the PREEMPT Chronic Migraine Study Group OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50:921–963. doi: 10.1111/j.1526-4610.2010.01678.x. - DOI - PubMed
-
- Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Sirimanne M, Degryse RE, Turkel CC (2009) OnabotulinumtoxinA for treatment of chronic migraine: analysis of the PREEMPT chronic migraine subgroup who were overusing acute headache medications at baseline. In: 14th international headache congress, Philadelphia, PA, September 2009
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
